Home
About Us
Our Team
The Urihk Partnership
Products
Antibiotic
Antifungal
Antioxidant
Immuno modulator
Neuro/CNS
Services
Learn More
News
Gallery
Careers
Contact Us
Select Page
Back
Oct 23, 2021
In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study.
Oct 23, 2021
Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis
Oct 23, 2021
Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin
Oct 23, 2021
Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections
